Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Post by Valuehunter72on Jun 22, 2020 7:52pm
128 Views
Post# 31178845

PP will not close

PP will not close

Buying opportunity coming up.

Looks like they are fumbling the ball again.

Came out with the first initial preclinical results that they deemed positive yet still needed to be independently verified, ....remember the fancy presentation on their website.  They mentioned five other tests that needed to be performed.....then that was the last we heard from the lab.  That was April 13th.  10 weeks ago......then nothing from the lab.

 

2020-04-13 08:42 ET - News Release

 

Mr. David Goren reports

VAXIL PROVIDES UPDATE ON PRECLINICAL EXPERIMENT

Vaxil Bio Ltd. has shared the results of its first preclinical experiment whose purpose was to test the immune response of its COVID-19 vaccine candidate. These results provide the first preclinical validation of the company's in silico modelling announced a few weeks ago.

May 5th....Announce deal with Tel Aviv hospital access to blood bank and testing....no need for further funding...

May 26th....  Yeah OK....we need funding.  Sorry to all those that recently invested and bought up our warrants to place 1.4 million in our account.  That actually was not enough even though we said we were good three weeks ago.

May 27th till now....silence from the company leaving investors head scratching wondering what the sudden reversal of need for funding was?


Speculation that funds required to finance phase 1 as the Strategic Innovation FUND of Canada requires a company to come up with 50% of funds and they will match the rest.  Company has not commented or released any information regarding this.

If you follow this link that I first noticed May 30th....you will be left puzzled as you read it over.   Funding expected in current year "YES"

https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/clntSmmry?clientOrgCorpNumber=366563&sMdKy=1590856256498&V_TOKEN=1590856256498

And also here under Lester Scheininger

https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/clntSmmry?clientOrgCorpNumber=366559&sMdKy=1591402431278


Now the interesting thing about Lester is he is very politically connected with the Liberal party and could help make this happen for Vaxil.

Lester Scheininger is a politician and lawyer in Ontario, Canada. He is best known for serving as president of the Canadian Jewish Congressfrom 1989-92. Scheininger ran for the Legislative Assembly of Ontario in the 1995 provincial election as a candidate of the Ontario Liberal Party.

https://en.wikipedia.org/wiki/Les_Scheininger


 

And this article was published May 10th.  You will need to scroll down a little to find the blurb on Vaxil.

Vaxil Bio Therapeutics Ltd. was registered by lawyer Lester Scheininger and company president David Goren. They will seek funding for a COVID-19 vaccine and clinical trials.


https://ipolitics.ca/2020/05/10/lobby-wrap-new-registrations-surge-to-74-last-week-amid-covid-19-pandemic/


So, this Thursday will be the target date closing for the PP, but like many other PP's....it is simply the target date.  "On or around"

 


So....are they fumbling the ball?

Are they using the Covid play to fill coffers for years to come to keep lights on and pay salaries?

Are they loading cash to take advantage of 50% grant funding to advance to phase 1 without the need of a major?

The company is certainly remaining silent as this second wave approaches and they have a golden opportunity to time an announcement should they actually have something.

Trolls have started reappearing......makes me think they have something.

Get ready for the dip.

Do your own DD.

Best,

Hunter




 

<< Previous
Bullboard Posts
Next >>